InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Thomsen Jillian B., Directrice comptable principale. Officer active across 2 companies, notably NEKTAR THERAPEUTICS. Cumulatively, 13 filings have been recorded. Breakdown: 0 buy · 7 sells. Total volume traded: €448k. History available since 17 May 2021. The latest transaction was disclosed on 16 February 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Thomsen Jillian B.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
10,267 shares@ US$3.004.6% of flowCommon StockSEC:0001209191-23-010953:0
11,095 shares@ US$3.576.1% of flowCommon StockSEC:0001209191-22-057966:0
165,938 shares0Common StockSEC:0001209191-22-046487:0
10,950 shares0Common StockSEC:0001209191-22-029903:0
2,363 shares@ US$10.950.0010% mcap4.1% of flowCommon StockSEC:0001209191-22-011439:0
21,200 shares0Common StockSEC:0001209191-21-070693:0
14,900 shares0Common StockSEC:0001209191-21-065223:0
13,339 shares@ US$13.8335.0% of flowCommon StockSEC:0001209191-21-052390:0
13,391 shares@ US$18.3045.0% of flowCommon StockSEC:0001209191-21-034188:0
15,000 sharesCommon StockSEC:0001209191-16-098170:0
15,000 sharesCommon StockSEC:0001209191-16-098170:1
15,000 sharesCommon StockSEC:0001209191-16-092947:0
15,000 sharesCommon StockSEC:0001209191-16-092947:1
13 of 13 declarations
About Thomsen Jillian B.
Thomsen Jillian B. is Directrice comptable principale and Chief Financial Officer at NEKTAR THERAPEUTICS (XNAS). She has filed 13 disclosures in total, and across the 13 recent filings available, the recorded transactions are sales for EUR 448014, between 2016-01-21 and 2023-02-17.
